|View printer-friendly version|
|Announcement for the acquisition of Abaxia on behalf of HTC France Corporation|
1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g.dividend yield):Abaxia
2.Date of occurrence of the event:2010/06/07
3.Volume, unit price, and total monetary amount of the transaction:Volume: 550,110 ordinary shares, 227,523 preferred shares; total monetary amount: EUR$11,000,000
4.Counterpart to the trade and its relationship to the Company (if the trading counterpart is a natural person and furthermore is not an actual related party of the Company, the name of the trading counterpart is not required to be disclosed):Original shareholders of Abaxia Relationship to the Company:none
5.Where the counterpart to the trade is an actual related party, a public announcement shall also be made of the reason for choosing the related party as trading counterpart and the identity of the previous owner (including its relationship with the company and the trading counterpart), price of transfer, and date of acquisition:N/A
6.Where a person who owned the property within the past five years has been an actual related person of the company, a public announcement shall also include the dates and prices of acquisition and disposal by the related person and the person’s relationship to the company at those times:N/A
7.Matters related to the creditor's rights currently being disposed of (including types of collateral of the disposed creditor's rights; if the creditor's rights are creditor's rights toward a related person, the name of the related person and the book amount of the creditor's rights toward such related person currently being disposed of must also be announced):N/A
8.Anticipated profit or loss from the disposal (not applicable in cases of acquisition of securities) (where originally deferred, the status or recognition shall be stated and explained):N/A
9.Terms of delivery or payment (including payment period and monetary amount), restrictive covenants in the contract, and other important stipulations:
1.Terms of delivery or payment: After the contract is signed, it is estimated that payment will be made in the end of June.
2.Restrictive covenants in the contract, and other important stipulations：None
10.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department:
1.Grand Cathay Securities Corporation’s opinion regarding the reasonableness of the transaction price. The transaction price is negotiated by parties involved.
2.The Board of Directors authorized the Chairperson to approve and execute the investment.
11.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):The cumulative shareholding of Abaxia (including the current trade) owned by HTC France Corporation is 550,110 ordinary shares and 227,523 preferred shares and amount is EUR$11,000,000. The shareholding percentage is 100%. There is no restriction of rights.
12.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:
(1)Ratio of the total amount of long or short term securities investment (including the current trade) to the total assets on the financial statement for the most recent period:HTC France Corporation：169%
(2)Ratio of the total amount of long or short term securities investment (including the current trade) to the shareholder's equity on the financial statement for the most recent period:HTC France Corporation：169%
(3)Operating capital as shown in the most recent financial statement:HTC France Corporation：EUR$6,500,000
13.Broker and broker's fee:N/A
14.Concrete purpose or use of the acquisition or disposition:Long-term investment
15.Net worth per share of company underlying securities acquired or disposed of:N/A
16.Do the directors have any objection to the present transaction?:N/A
17.Has the CPA issued an opinion on the unreasonableness of the price of the current transaction?:N/A
18.Any other matters that need to be specified:N/A